CSIMarket
 

Blue Line Protection Group Inc   (BLPG)
    Sector  Retail    Industry Specialty Retail
   Industry Specialty Retail
   Sector  Retail

Blue Line Protection Group Inc 's

Competitiveness




 

BLPG Sales vs. its Competitors Q1 2025



Comparing the current results to its competitors, Blue Line Protection Group Inc reported Revenue decrease in the 1 quarter 2025 year on year by -9.09 %, despite the revenue increase by the most of its competitors of 2.95 %, recorded in the same quarter.

List of BLPG Competitors

With a net margin of 0.37 % Blue Line Protection Group Inc reported lower profitability than its competitors.

More on BLPG Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Blue Line Protection Group Inc Net Income in the 1 quarter 2025 fell year on year by -97.58%, while most of its competitors have experienced a contraction in net income by -41.23 %.

<<  BLPG Stock Performance Comparisons


Blue Line Protection Group Inc 's Comment on Competition and Industry Peers


The company operates in the legal cannabis industry, which is projected to reach $35 billion in retail sales by 2025. It competes based on expertise, service quality, and price, leveraging advantages such as brand recognition, reputation, regulatory and banking compliance expertise, operational capabilities, cash processing, transportation and storage services, security and logistics infrastructure, and economies of scale. The market is highly fragmented and nascent, particularly in security and storage solutions for legal marijuana companies. The company faces competition from firms of various sizes offering regulatory compliance, armored transportation, and cash processing services. Some competitors benefit from lower costs due to factors such as lower wages and less stringent standards. Larger security services companies with greater resources also compete in this sector.



  

Overall company Market Share Q1 2025

Overall company, revenue fell by -9.09 % and company lost market share, to approximately 0.04 %.




<<  More on BLPG Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Blue Line Protection Group Inc




Vertex Pharmaceuticals Inc
Share Performance



+16.98%
This Year



Vertex Pharmaceuticals Inc
Profile

Vertex Pharmaceuticals Incs business model centers on the research and development of innovative therapies, primarily targeting cystic fibrosis and other serious diseases. They emphasize collaboration with organizations, strategic partnerships, and robust investment in R&D to deliver transformative treatments to patients and enhance their quality of life.

More about Vertex Pharmaceuticals Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 134,975.280 mill. $ 12,587.200 mill. $ 4,405.200 mill.

Sources: Blue Line Protection Group Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Blue Line Protection Group Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.